Skip to search formSkip to main contentSkip to account menu

3-hydroxypyridin-2-one

Known as: CP02 indium 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Chelation therapy has become an important therapeutic approach for some diseases. In attempt to identify clinically useful… 
2017
2017
  • F. Perdih
  • Acta crystallographica. Section C, Structural…
  • 2017
  • Corpus ID: 4231731
Copper(II) bis(4,4,4-trifluoro-1-phenylbutane-1,3-dionate) complexes with pyridin-2-one (pyon), 3-hydroxypyridine (hpy) and 3… 
2016
2016
A novel octadentate 3-hydroxypyridin-2-one (2,3-HOPO) based di-macrocyclic ligand was evaluated for chelation of 89Zr… 
2014
2014
El presente trabajo se enmarca en el desarrollo del proyecto UBACyT CP02:“Evaluacion de modalidades de intervencion en el ambito… 
2012
2012
Organometallic RuII compounds are among the most widely studied anticancer agents. Functionalizing metal centers with biomolecule… 
Review
2004
Review
2004
  • S. Iqbal, H. Lenz
  • Cancer Chemotherapy and Pharmacology
  • 2004
  • Corpus ID: 20861262
Two of the most promising new targets in the treatment of colorectal cancer are the epithelial growth factor receptor (EGFR) and… 
2004
2004
In order to identify new compounds which label platelets without affecting their function, three classes of metal chelating…